Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

3.020

-0.030 (-0.98%)

At close: Aug 14, 2026, 4:00 PM EDT

3.040

+0.020 (0.66%)

After-hours: Aug 14, 2026, 7:42 PM EDT

Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66.59	64.64	44.51	27.17	20.29	28.02
Cash & Short-Term Investments	66.59	64.64	44.51	27.17	20.29	28.02
Cash Growth	10.39%	45.22%	63.80%	33.93%	-27.59%	69.84%
Receivables	8.58	9.74	7.77	5.23	8.48	5.23
Inventory	20.64	20.42	9.19	14.53	14.68	13.6
Prepaid Expenses	1.83	1.31	2.48	2.45	2.97	1.86
Restricted Cash	0.15	0.15	0.15	0.15	0.15	0.2
Other Current Assets	-	0.54	-	-	-	-
Total Current Assets	97.79	96.81	64.1	49.53	46.57	48.91
Property, Plant & Equipment	3.09	3.52	3.45	4.54	6.32	7.36
Other Intangible Assets	5.31	5.66	0.36	0.51	0.67	0.86
Other Long-Term Assets	0.41	0.43	0.37	0.38	0.5	0.72
Total Assets	106.59	106.41	68.28	54.96	54.06	57.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	9.44	10.8	8.53	10.23	9.68	10.42
Accrued Expenses	3.84	7.72	7.82	9.49	7.34	6.48
Current Portion of Leases	0.92	1	0.99	0.7	0.7	0.55
Current Unearned Revenue	0.33	0.4	0.61	0.2	0.16	0.16
Other Current Liabilities	0.52	-	-	-	-	-
Total Current Liabilities	15.05	19.92	17.95	20.62	17.87	17.61
Long-Term Leases	1.41	1.82	1.66	2.58	3.56	4.15
Long-Term Unearned Revenue	2.43	2.67	2.58	3.31	3.96	4.35
Other Long-Term Liabilities	5.17	5.47	-	-	-	-
Total Liabilities	24.06	29.87	22.18	26.51	25.39	26.11

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.08	0.08	0.08	0.08	0.07	0.07
Additional Paid-In Capital	239.7	240.99	227.93	218.85	214.09	200.61
Retained Earnings	-157.25	-164.53	-181.91	-190.46	-185.49	-168.95
Comprehensive Income & Other	-0	-0.01	-0	-0	-0	-0
Shareholders' Equity	82.53	76.53	46.09	28.46	28.67	31.73
Total Liabilities & Equity	106.59	106.41	68.28	54.96	54.06	57.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.33	2.82	2.65	3.28	4.26	4.7
Net Cash (Debt)	64.26	61.82	41.86	23.9	16.03	23.32
Net Cash Growth	12.68%	47.69%	75.16%	49.05%	-31.24%	56.91%
Net Cash Per Share	0.76	0.72	0.54	0.32	0.23	0.35
Filing Date Shares Outstanding	79.29	80.25	77.92	75.48	75.02	68.49
Total Common Shares Outstanding	79.08	79.88	77.5	75.15	74.75	68.31
Working Capital	82.74	76.89	46.15	28.91	28.7	31.29
Book Value Per Share	1.04	0.96	0.59	0.38	0.38	0.46
Tangible Book Value	77.22	70.87	45.74	27.95	28	30.87
Tangible Book Value Per Share	0.98	0.89	0.59	0.37	0.37	0.45
Machinery	-	3.54	3.97	4.26	4.05	4.3
Construction In Progress	-	0.05	0.09	0.01	0.17	0.09
Leasehold Improvements	-	2.21	2.21	2.15	2.06	2.39

SEC Filings: 10-K · 10-Q